Lipid nanoparticles as a promising drug delivery carrier for topical ocular therapy—an overview on recent advances

S Jacob, AB Nair, J Shah, S Gupta, SHS Boddu… - Pharmaceutics, 2022 - mdpi.com
Due to complicated anatomical and physical properties, targeted drug delivery to ocular
tissues continues to be a key challenge for formulation scientists. Various attempts are …

Cannabinoid formulations and delivery systems: Current and future options to treat pain

B Stella, F Baratta, C Della Pepa, S Arpicco, D Gastaldi… - Drugs, 2021 - Springer
The field of Cannabis sativa L. research for medical purposes has been rapidly advancing in
recent decades and a growing body of evidence suggests that phytocannabinoids are …

Untangling mucosal drug delivery: engineering, designing, and testing nanoparticles to overcome the mucus barrier

J Watchorn, AJ Clasky, G Prakash… - ACS Biomaterials …, 2022 - ACS Publications
Mucus is a complex viscoelastic gel and acts as a barrier covering much of the soft tissue in
the human body. High vascularization and accessibility have motivated drug delivery to …

Recent progress of solid lipid nanoparticles and nanostructured lipid carriers as ocular drug delivery platforms

V Gugleva, V Andonova - Pharmaceuticals, 2023 - mdpi.com
Sufficient ocular bioavailability is often considered a challenge by the researchers, due to
the complex structure of the eye and its protective physiological mechanisms. In addition, the …

[HTML][HTML] An insight on lipid nanoparticles for therapeutic proteins delivery

C Viegas, F Seck, P Fonte - Journal of Drug Delivery Science and …, 2022 - Elsevier
Therapeutic proteins are well-tolerated bioactive compounds used in different therapies, due
to its high specificity and biopotency. Nevertheless, they may also present some …

Overview of solid lipid nanoparticles in breast cancer therapy

K Mo, A Kim, S Choe, M Shin, H Yoon - Pharmaceutics, 2023 - mdpi.com
Lipid nanoparticles (LNPs), composed of ionized lipids, helper lipids, and cholesterol,
provide general therapeutic effects by facilitating intracellular transport and avoiding …

Lipid-based nanocarriers for ophthalmic administration: towards experimental design implementation

FM González-Fernández, A Bianchera, P Gasco… - Pharmaceutics, 2021 - mdpi.com
Nanotherapeutics based on biocompatible lipid matrices allow for enhanced solubility of
poorly soluble compounds in the treatment of ophthalmic diseases, overcoming the …

Topical drug delivery to the retina: obstacles and routes to success

T Loftsson - Expert Opinion on Drug Delivery, 2022 - Taylor & Francis
Introduction Retinal diseases are one of the main reasons for vision loss where all available
drug treatments are based on invasive drug administration such as intravitreal injections …

Antimicrobial nanomedicine for ocular bacterial and fungal infection

W Fan, H Han, Y Chen, X Zhang, Y Gao, S Li… - Drug Delivery and …, 2021 - Springer
Ocular infection induced by bacteria and fungi is a major cause of visual impairment and
blindness. Topical administration of antibiotics remains the first-line treatment, as effective …

Antibiotic-loaded lipid-based nanocarrier: A promising strategy to overcome bacterial infection

MAB Henostroza, GD Tavares, MN Yukuyama… - International Journal of …, 2022 - Elsevier
Abstract According to the World Health Organization (WHO) and Centers for Disease Control
and Prevention (CDC), bacterial infections are one of the greatest threats to global health …